Genetic Disease Program
Program Home
About the Program
Introduction
Our Staff
Financial Issues
Directions
Contact Us
Genetic Family History
Family History Forms
Recommended Treatments
Ethics of Genetic Testing
Inheritance Patterns
Conditions
Cancer
Breast/Ovarian Cancer
Colorectal Cancer
Cardiac
Long QT Syndrome
HCM
Other
Blood Clots
Hemachromatosis
Pregnancy Problems
Pharmacogenetics
 
What’s New in Genetics?
 
Adult Onset Genetic Disease ProgramConditionsHemochromatosis Printer Friendly Page
Iron is an important nutrient for a healthy body. In people who have hemochromatosis, however, excess iron is absorbed by the body. With no natural way to eliminate the extra iron, the body stores it in certain tissues, such as those in the liver, heart and pancreas. Too much iron can critically damage these organs, causing cirrhosis, congestive heart failure, and possibly diabetes. Hemochromatosis can also result in arthritis, thyroid deficiency, impotence, and early menopause. Damage to pigmentation can make the person’s skin appear bronze or gray.

The symptoms of hemochromatosis vary, but joint pain is commonly experienced. Fatigue, pain in the abdomen, cardiac problems, and a loss of sex drive are other symptoms that some, but not all, people with hemochromatosis report. In some cases, the person does not have any unusual symptoms.

Hemochromatosis is a heritable disorder with five distinct types. Three of them—Hemochromatosis Types 1, 2, and 3—are autosomal recessive conditions. Hemochromatosis Type 4 has an autosomal dominant pattern of inheritance. The fifth type, Hemochromatosis, neonatal, is extremely rare, and its inheritance pattern is not yet known. The most common form of the disorder is Type 1, affecting about 1 million people in the United States.

Clinical tests for hemochromatosis include a transferrin saturation test and a serum ferritin test, which measure the liver’s iron levels. Typically, geneticists test a person’s blood for two gene mutations, C282Y and H63D. The mutations indicate an interference with the normal metabolism of iron. The DNA test for hemochromatosis has a detection rate of about 87 percent..

With hemochromatosis, primarily an autosomal recessive disorder, it is important to test for carriers of the mutant genes. These people do not have hemochromatosis themselves, but carry one of the defective genes. So, if a person is found to have hemochromatosis, it is recommended that his or her siblings, parents, and children consider having the genetic test. People with otherwise unexplainable high levels of iron, severe fatigue, joint disease, heart disease, or diabetes are possible candidates for testing, as well.

Hemochromatosis is treatable, but not curable. The goal is to eliminate excess iron from the blood, and the most common way to do that is by drawing the patient’s blood until the blood ferritin levels are acceptable. Not many people like getting their blood taken, but by doing so, they may be able to prevent damage to vital organs or reduce the severity of iron overload’s effects. Cirrhosis is one condition that does not improve after the phlebotomy regimen, and if the patient has developed cirrhosis, his or her chances of having liver cancer increases. To avoid possible damage to the liver, any person with hemochromatosis should avoid drinking alcoholic beverages and not take iron supplements.

Return to Top Printer Friendly Page